CA2163762A1 — Combination of an intra-uterine contraceptive design and an insertion device
Assigned to Bayer Pharma AG · Expires 1994-12-08 · 31y expired
What this patent protects
The invention is a combination (100) of a device (1) with body (5), arms (6 and 6') and an attachment part (8) and of an insert device, (2) tube (3), and stem (4). At one end the tube (3) is equipped with a spring (11) which is situated between a rod mounting (10) and the caudal …
USPTO Abstract
The invention is a combination (100) of a device (1) with body (5), arms (6 and 6') and an attachment part (8) and of an insert device, (2) tube (3), and stem (4). At one end the tube (3) is equipped with a spring (11) which is situated between a rod mounting (10) and the caudal end (12) of the tube. The stem (4) is equipped with a stem mounting (15) at its caudal end.
Drugs covered by this patent
- Jadelle (LEVONORGESTREL) · Fdn Consumer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.